These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 24732804)
1. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents. Jutooru I; Guthrie AS; Chadalapaka G; Pathi S; Kim K; Burghardt R; Jin UH; Safe S Mol Cell Biol; 2014 Jul; 34(13):2382-95. PubMed ID: 24732804 [TBL] [Abstract][Full Text] [Related]
2. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063 [TBL] [Abstract][Full Text] [Related]
3. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786 [TBL] [Abstract][Full Text] [Related]
4. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a. Li W; Liu M; Xu YF; Feng Y; Che JP; Wang GC; Zheng JH Oncol Rep; 2014 Jan; 31(1):117-24. PubMed ID: 24173369 [TBL] [Abstract][Full Text] [Related]
5. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401 [TBL] [Abstract][Full Text] [Related]
6. Benzyl Isothiocyanate (BITC) Induces Reactive Oxygen Species-dependent Repression of STAT3 Protein by Down-regulation of Specificity Proteins in Pancreatic Cancer. Kasiappan R; Jutooru I; Karki K; Hedrick E; Safe S J Biol Chem; 2016 Dec; 291(53):27122-27133. PubMed ID: 27875298 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. Jutooru I; Chadalapaka G; Lei P; Safe S J Biol Chem; 2010 Aug; 285(33):25332-44. PubMed ID: 20538607 [TBL] [Abstract][Full Text] [Related]
8. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters. Kim K; Chadalapaka G; Pathi SS; Jin UH; Lee JS; Park YY; Cho SG; Chintharlapalli S; Safe S Mol Cancer Ther; 2012 Sep; 11(9):1852-62. PubMed ID: 22752225 [TBL] [Abstract][Full Text] [Related]
9. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis. Noratto GD; Jutooru I; Safe S; Angel-Morales G; Mertens-Talcott SU Mol Nutr Food Res; 2013 Sep; 57(9):1638-48. PubMed ID: 23471840 [TBL] [Abstract][Full Text] [Related]
10. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors. Karki K; Hedrick E; Kasiappan R; Jin UH; Safe S Cancer Prev Res (Phila); 2017 Aug; 10(8):467-477. PubMed ID: 28673967 [TBL] [Abstract][Full Text] [Related]
11. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a. Jutooru I; Chadalapaka G; Abdelrahim M; Basha MR; Samudio I; Konopleva M; Andreeff M; Safe S Mol Pharmacol; 2010 Aug; 78(2):226-36. PubMed ID: 20488920 [TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors. Hedrick E; Crose L; Linardic CM; Safe S Mol Cancer Ther; 2015 Sep; 14(9):2143-53. PubMed ID: 26162688 [TBL] [Abstract][Full Text] [Related]
13. Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors. Kasiappan R; Jutooru I; Mohankumar K; Karki K; Lacey A; Safe S Mol Cancer Res; 2019 Mar; 17(3):794-805. PubMed ID: 30610105 [TBL] [Abstract][Full Text] [Related]
14. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10. Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a. Del Follo-Martinez A; Banerjee N; Li X; Safe S; Mertens-Talcott S Nutr Cancer; 2013; 65(3):494-504. PubMed ID: 23530649 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-Specificity Protein (Sp) Transcription Factor Interactions and Significance in Carcinogenesis. Safe S Curr Pharmacol Rep; 2015 Apr; 1(2):73-78. PubMed ID: 26457240 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells. Pathi SS; Lei P; Sreevalsan S; Chadalapaka G; Jutooru I; Safe S Nutr Cancer; 2011; 63(7):1133-42. PubMed ID: 21919647 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells. Li X; Mertens-Talcott SU; Zhang S; Kim K; Ball J; Safe S Endocrinology; 2010 Jun; 151(6):2462-73. PubMed ID: 20382698 [TBL] [Abstract][Full Text] [Related]
19. Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells. Chadalapaka G; Jutooru I; Safe S Carcinogenesis; 2012 Apr; 33(4):886-94. PubMed ID: 22334592 [TBL] [Abstract][Full Text] [Related]
20. Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells. Hedrick E; Cheng Y; Jin UH; Kim K; Safe S Oncotarget; 2016 Apr; 7(16):22245-56. PubMed ID: 26967243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]